☆ 4.8 Article

Predictors for reactogenicity and humoral immunity to SARS-CoV-2 following infection and mRNA vaccination: A regularized, mixed-effects modelling approach

FRONTIERS IN IMMUNOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Multidisciplinary Sciences

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Peter B. Gilbert et al.

Summary: In the COVE phase 3 clinical trial, neutralizing and binding antibodies were measured in vaccine recipients to determine their correlation with COVID-19 risk and vaccine efficacy. The results showed that these immune markers were inversely associated with COVID-19 risk and directly associated with vaccine efficacy. Postvaccination neutralization titers of 10, 100, and 1000 correlated with estimated vaccine efficacies of 78%, 91%, and 96% respectively.

SCIENCE (2022)

添加到收藏夹

Article Medicine, Research & Experimental

SARS-CoV-2 BNT162b2 vaccine-induced humoral response and reactogenicity in individuals with prior COVID-19 disease

Steven G. Kelsen et al.

Summary: Individuals with prior COVID-19 disease show a different immune and reactogenicity response to the BNT162b2 vaccine compared to those without prior COVID-19 infection. The COVID-19 group has a stronger and faster immune response after the first dose but a weaker response after the second dose of the vaccine. They also experience more adverse reactions.

JCI INSIGHT (2022)

添加到收藏夹

Article Infectious Diseases

Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis

Matias J. Pereson et al.

Summary: The study compares the effectiveness of homologous and heterologous vaccine combinations and finds that the heterologous SpV/Mod combination significantly enhances humoral immune response and is well tolerated by most individuals.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

添加到收藏夹

Review Medicine, General & Internal

Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents

Maria K. Smatti et al.

Summary: The emerging field of immunogenomics, which combines immunology and genetics, has shed light on how the immune system responds to infection and vaccination. While extensive research is being conducted on the immunogenetic basis of the clinical variability in response to SARS-CoV-2 infection, the genetic factors influencing response to SARS-CoV-2 vaccines remain largely unknown. Understanding the role of host genetics in vaccine-induced immunity could lead to personalized vaccine strategies to optimize vaccine response.

FRONTIERS IN MEDICINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England

Matthew Whitaker et al.

Summary: This study assesses changing symptom profiles associated with different SARS-CoV-2 variants in England from May 2020 to March 2022. The authors find that Omicron infection is more often associated with cold and influenza-like symptoms, and less with loss of taste and smell. Contrary to the perception that recent variants have become milder, Omicron BA.2 was associated with reporting more symptoms and greater disruption to daily activities than BA.1.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

COVID-19-neutralizing antibodies predict disease severity and survival

Wilfredo F. Garcia-Beltran et al.

Summary: Severe cases of COVID-19 show increased inflammatory markers, lymphopenia, pro-inflammatory cytokines, and high antibody levels. High neutralization potency is a predictor of survival. Patient sera can neutralize different strains, indicating cross-protection from reinfection.

CELL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Shuo Feng et al.

Summary: Defined levels of SARS-CoV-2-specific binding and neutralizing antibodies elicited by the COVID-19 vaccine were identified as correlates of protection against symptomatic infection. Higher levels of immune markers were correlated with a reduced risk of symptomatic infection. The data can be used to extrapolate efficacy estimates to new populations.

NATURE MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Einav G. Levin et al.

Summary: A study in Israel revealed that waning immunity after receiving two doses of the BNT162b2 vaccine led to an increase in the incidence of SARS-CoV-2 infection. Levels of spike-binding IgG and neutralizing antibodies decreased more significantly in men, individuals aged 65 or older, and immunosuppressed individuals in a longitudinal study involving nearly 4000 healthcare workers.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Immunology

Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers

Suresh Pallikkuth et al.

Summary: This study found a correlation between influenza specific T cell immunity and immune responses to SARS-CoV-2 in healthcare workers who had past SARS-CoV-2 infection, suggesting a potential impact on immunity against COVID-19.

VACCINE (2021)

添加到收藏夹

Article Immunology

Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time

Thomas L. Rodebaugh et al.

Summary: The progression of COVID-19 symptoms during the initial weeks is highly diverse, with significant variations among individuals. Some patients experience persistently severe symptoms or develop new symptoms days after diagnosis. Those who show clinical deterioration are more likely to have severe cough and diarrhea symptoms.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia

Elizabeth T. Rogawski McQuade et al.

Summary: This statewide study in Virginia found that 2.4% of adults had been exposed to SARS-CoV-2, significantly higher among Hispanic individuals, those living in multifamily units, and those in contact with confirmed COVID-19 cases. Most infections were asymptomatic, indicating a largely immunologically naive population in Virginia as of August 2020.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Medicine, General & Internal

Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune response

Jesus Ontanon et al.

Summary: The study shows that at least ten months post-COVID-19 infection, the immune system is still capable of producing a rapid and powerful secondary antibody response following one single vaccine dose. There was a significant increase in antibody levels after the second dose in naive HCWs, while experienced HCWs showed no further improvement in antibody response to the second dose.

EBIOMEDICINE (2021)

添加到收藏夹

Article Immunology

Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers

Ricardo da Silva Antunes et al.

Summary: The study found that SARS-CoV-2 seronegative healthcare workers had higher CD4(+) T-cell responses against common cold coronaviruses, possibly due to higher occupational exposure. Additionally, exposure to SARS-CoV-2 may decrease T-cell reactivity against common cold coronaviruses, as observed in independent cohorts from Miami and San Diego.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Microbiology

Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan

Mayu Nagura-Ikeda et al.

Summary: Serological tests for COVID-19 play an important role in surveillance and diagnosis. This study aimed to evaluate the clinical utility of VITROS SARS-CoV-2 antibody tests in patients with different severity of COVID-19 in Japan. The intensity of total and IgG antibodies was significantly higher in severe cases compared to mild cases, especially after 11 days of symptom onset.

JOURNAL OF MEDICAL MICROBIOLOGY (2021)

添加到收藏夹

Article Virology

Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection

Annapaola Callegaro et al.

Summary: A single mRNA vaccine dose seems sufficient to provide immunity in individuals with previous SARS-CoV-2 infection, showing similar results to a full vaccine schedule. Adverse events after vaccination were more common after the second dose, with higher frequency in exposed individuals compared to naive ones.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

Mark S. Graham et al.

Summary: The study showed that the B.1.1.7 variant did not result in changes in COVID-19 symptoms or duration of illness, and there was no significant increase in reinfection rate compared to previous variants.

LANCET PUBLIC HEALTH (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Personalized health and the coronavirus vaccines-Do individual genetics matter?

Bianca N. Valdes-Fernandez et al.

Summary: Vaccines can have variable safety and efficacy due to genetic variability among individuals, leading to different immune responses. The technology and genetic differences in recipients may result in vaccines against COVID-19 triggering distinct immune reactions, potentially signaling a new era of personalized healthcare.

BIOESSAYS (2021)

添加到收藏夹

Letter Virology

Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection, and change to single-dose vaccination

Rujittika Mungmunpuntipantip et al.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Cell Biology

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

Daniel Lozano-Ojalvo et al.

Summary: The study found that the second dose of the vaccine increases immunity in naive individuals, while those who previously recovered from COVID-19 reach their peak immunity after the first dose. This suggests that a second dose may not be necessary for individuals who have been infected with SARS-CoV-2 before.

CELL REPORTS (2021)

添加到收藏夹

Article Immunology

Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination

Lisa Mueller et al.

Summary: The study compared antibody responses to the BNT162b2 COVID-19 vaccine in young vaccinees below 60 and elderly vaccinees over 80. The elderly group had lower antibody titers and a lower frequency of neutralizing antibodies post-vaccination, indicating a potential need for closer monitoring or different vaccination strategies for this population.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Katharine H. D. Crawford et al.

Summary: Antibody levels, including neutralizing antibodies, decline after SARS-CoV-2 infection, with a 4-fold average decrease in titers from 1 to 4 months after symptom onset. This decline is accompanied by a decrease in total antibodies capable of binding the viral spike protein. Further studies are needed to determine the long-term durability of immunity to SARS-CoV-2, including examination of long-lived B cells and antibody titers over extended periods.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat et al.

NATURE MEDICINE (2020)

添加到收藏夹

Review Medicine, General & Internal

Clinical presentation and management ofCOVID-19

Irani Thevarajan et al.

MEDICAL JOURNAL OF AUSTRALIA (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

Jose Mateus et al.

SCIENCE (2020)

添加到收藏夹

Review Immunology

Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?

John S. Tsang et al.

TRENDS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Humoral Immune Response to SARS-CoV-2 in Iceland

Daniel F. Gudbjartsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Immunology

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

Katharina Roltgen et al.

SCIENCE IMMUNOLOGY (2020)

添加到收藏夹

Review Immunology

Defining trained immunity and its role in health and disease

Mihai G. Netea et al.

NATURE REVIEWS IMMUNOLOGY (2020)

添加到收藏夹

Review Microbiology

Factors That Influence the Immune Response to Vaccination

Petra Zimmermann et al.

CLINICAL MICROBIOLOGY REVIEWS (2019)

添加到收藏夹

Review Immunology

The how's and what's of vaccine reactogenicity

Caroline Herve et al.

NPJ VACCINES (2019)

添加到收藏夹

Review Immunology

Adversomics: a new paradigm for vaccine safety and design

Jennifer A. Whitaker et al.

EXPERT REVIEW OF VACCINES (2015)

添加到收藏夹

Article Infectious Diseases

Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth

Robert F. Pass et al.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2013)

添加到收藏夹

Article Computer Science, Interdisciplinary Applications

Regularization Paths for Generalized Linear Models via Coordinate Descent

Jerome Friedman et al.

JOURNAL OF STATISTICAL SOFTWARE (2010)

添加到收藏夹

Letter Medicine, General & Internal

Responses to 2009 H1N1 Vaccine in Children 3 to 17 Years of Age

Adriano Arguedas et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

添加到收藏夹

Review Mathematical & Computational Biology

Simultaneous inference in general parametric models

Torsten Hothorn et al.

BIOMETRICAL JOURNAL (2008)

添加到收藏夹

Article Statistics & Probability

Stable and efficient multiple smoothing parameter estimation for generalized additive models

SN Wood

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.